Valuation (2%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.70 | N/A |
| PEG Ratio (TTM) | -0.08 | N/A |
| P/S Ratio (TTM) | 6.71 | N/A |
| P/B Ratio (TTM) | -25.47 | N/A |
| P/FCF Ratio (TTM) | -0.72 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.17 | N/A |
| Price to 5YR AVG FCF Ratio | -0.35 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -263.65% | N/A |
| ROE (TTM) | 28,172.73% | N/A |
| Net Profit Margin (TTM) | -1,303.93% | N/A |
| ROIC 5YR AVG | -165.38% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 38.86% | -242,347.39% | -145,429.20% |
| Revenue | 49.11% | -3.20% | 182.83% |
| Net Income | 13.26% | -164,071.22% | -98,473.08% |
| Cash Flow | -45.02% | -3,029.94% | -1,812.30% |
Health (7%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.38 | N/A |
| Quick Ratio (TTM) | 0.38 | N/A |
| D/E Ratio (TTM) | -0.68 | N/A |
| Interest Coverage (TTM) | -144.04 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -0.09 | N/A |
| Shares Outstanding Growth 5YR AVG | 14.45% | N/A |